Deutsche Bank Ag\ Omega Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.73 - $5.32 $29,126 - $56,759	10,669 Added 693.69%	12,207 $44,000
Q2 2023 Aug 14, 2023	BUY	$5.6 - $9.66 $8,612 - $14,857	1,538 New	1,538 $8,000
Q2 2022 Aug 11, 2022	SELL	$2.01 - $7.19 $24,797 - $88,703	-12,337 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $48,927 - $110,087	7,841 Added 174.4%	12,337 $77,000
Q4 2021 Feb 11, 2022	BUY	$11.33 - $29.38 $2,719 - $7,051	240 Added 5.64%	4,496 $51,000
Q3 2021 Nov 04, 2021	BUY	$16.0 - $22.51 $68,096 - $95,802	4,256 New	4,256 $80,000

43.3M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $6.22M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.